Global Intravitreal Injectable Market Analysis and Forecast 2024-2030

Global Intravitreal Injectable Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Intravitreal Injectable market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Intravitreal Injectable is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravitreal Injectable, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Intravitreal Injectable, also provides the sales of main regions and countries. Of the upcoming market potential for Intravitreal Injectable, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravitreal Injectable sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intravitreal Injectable market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intravitreal Injectable sales, projected growth trends, production technology, application and end-user industry.

Intravitreal Injectable segment by Company

Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Intravitreal Injectable segment by Drug
Anti-VEGF
Steroids
Others
Intravitreal Injectable segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Intravitreal Injectable segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravitreal Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravitreal Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravitreal Injectable.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Intravitreal Injectable in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravitreal Injectable sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Intravitreal Injectable Market by Drug
1.2.1 Global Intravitreal Injectable Market Size by Drug, 2019 VS 2023 VS 2030
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Intravitreal Injectable Market by Disease
1.3.1 Global Intravitreal Injectable Market Size by Disease, 2019 VS 2023 VS 2030
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Intravitreal Injectable Market Dynamics
2.1 Intravitreal Injectable Industry Trends
2.2 Intravitreal Injectable Industry Drivers
2.3 Intravitreal Injectable Industry Opportunities and Challenges
2.4 Intravitreal Injectable Industry Restraints
3 Global Market Growth Prospects
3.1 Global Intravitreal Injectable Revenue Estimates and Forecasts (2019-2030)
3.2 Global Intravitreal Injectable Revenue by Region
3.2.1 Global Intravitreal Injectable Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Intravitreal Injectable Revenue by Region (2019-2024)
3.2.3 Global Intravitreal Injectable Revenue by Region (2025-2030)
3.2.4 Global Intravitreal Injectable Revenue Market Share by Region (2019-2030)
3.3 Global Intravitreal Injectable Sales Estimates and Forecasts 2019-2030
3.4 Global Intravitreal Injectable Sales by Region
3.4.1 Global Intravitreal Injectable Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Intravitreal Injectable Sales by Region (2019-2024)
3.4.3 Global Intravitreal Injectable Sales by Region (2025-2030)
3.4.4 Global Intravitreal Injectable Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Intravitreal Injectable Revenue by Manufacturers
4.1.1 Global Intravitreal Injectable Revenue by Manufacturers (2019-2024)
4.1.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Intravitreal Injectable Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Intravitreal Injectable Sales by Manufacturers
4.2.1 Global Intravitreal Injectable Sales by Manufacturers (2019-2024)
4.2.2 Global Intravitreal Injectable Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Intravitreal Injectable Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Intravitreal Injectable Sales Price by Manufacturers (2019-2024)
4.4 Global Intravitreal Injectable Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Intravitreal Injectable Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Intravitreal Injectable Manufacturers, Product Type & Application
4.7 Global Intravitreal Injectable Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Intravitreal Injectable Market CR5 and HHI
4.8.2 2023 Intravitreal Injectable Tier 1, Tier 2, and Tier 3
5 Intravitreal Injectable Market by Type
5.1 Global Intravitreal Injectable Revenue by Type
5.1.1 Global Intravitreal Injectable Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Intravitreal Injectable Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Intravitreal Injectable Revenue Market Share by Type (2019-2030)
5.2 Global Intravitreal Injectable Sales by Type
5.2.1 Global Intravitreal Injectable Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Intravitreal Injectable Sales by Type (2019-2030) & (K Units)
5.2.3 Global Intravitreal Injectable Sales Market Share by Type (2019-2030)
5.3 Global Intravitreal Injectable Price by Type
6 Intravitreal Injectable Market by Application
6.1 Global Intravitreal Injectable Revenue by Application
6.1.1 Global Intravitreal Injectable Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Intravitreal Injectable Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Intravitreal Injectable Revenue Market Share by Application (2019-2030)
6.2 Global Intravitreal Injectable Sales by Application
6.2.1 Global Intravitreal Injectable Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Intravitreal Injectable Sales by Application (2019-2030) & (K Units)
6.2.3 Global Intravitreal Injectable Sales Market Share by Application (2019-2030)
6.3 Global Intravitreal Injectable Price by Application
7 Company Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Comapny Information
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
7.2 Allergan
7.2.1 Allergan Comapny Information
7.2.2 Allergan Business Overview
7.2.3 Allergan Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Allergan Intravitreal Injectable Product Portfolio
7.2.5 Allergan Recent Developments
7.3 EyePoint Pharmaceuticals
7.3.1 EyePoint Pharmaceuticals Comapny Information
7.3.2 EyePoint Pharmaceuticals Business Overview
7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
7.3.5 EyePoint Pharmaceuticals Recent Developments
7.4 Genentech
7.4.1 Genentech Comapny Information
7.4.2 Genentech Business Overview
7.4.3 Genentech Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Genentech Intravitreal Injectable Product Portfolio
7.4.5 Genentech Recent Developments
7.5 Kanghong Pharmaceutical
7.5.1 Kanghong Pharmaceutical Comapny Information
7.5.2 Kanghong Pharmaceutical Business Overview
7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
7.5.5 Kanghong Pharmaceutical Recent Developments
8 North America
8.1 North America Intravitreal Injectable Market Size by Drug
8.1.1 North America Intravitreal Injectable Revenue by Drug (2019-2030)
8.1.2 North America Intravitreal Injectable Sales by Drug (2019-2030)
8.1.3 North America Intravitreal Injectable Price by Drug (2019-2030)
8.2 North America Intravitreal Injectable Market Size by Disease
8.2.1 North America Intravitreal Injectable Revenue by Disease (2019-2030)
8.2.2 North America Intravitreal Injectable Sales by Disease (2019-2030)
8.2.3 North America Intravitreal Injectable Price by Disease (2019-2030)
8.3 North America Intravitreal Injectable Market Size by Country
8.3.1 North America Intravitreal Injectable Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Intravitreal Injectable Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Intravitreal Injectable Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Intravitreal Injectable Market Size by Drug
9.1.1 Europe Intravitreal Injectable Revenue by Drug (2019-2030)
9.1.2 Europe Intravitreal Injectable Sales by Drug (2019-2030)
9.1.3 Europe Intravitreal Injectable Price by Drug (2019-2030)
9.2 Europe Intravitreal Injectable Market Size by Disease
9.2.1 Europe Intravitreal Injectable Revenue by Disease (2019-2030)
9.2.2 Europe Intravitreal Injectable Sales by Disease (2019-2030)
9.2.3 Europe Intravitreal Injectable Price by Disease (2019-2030)
9.3 Europe Intravitreal Injectable Market Size by Country
9.3.1 Europe Intravitreal Injectable Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Intravitreal Injectable Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Intravitreal Injectable Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Intravitreal Injectable Market Size by Drug
10.1.1 China Intravitreal Injectable Revenue by Drug (2019-2030)
10.1.2 China Intravitreal Injectable Sales by Drug (2019-2030)
10.1.3 China Intravitreal Injectable Price by Drug (2019-2030)
10.2 China Intravitreal Injectable Market Size by Disease
10.2.1 China Intravitreal Injectable Revenue by Disease (2019-2030)
10.2.2 China Intravitreal Injectable Sales by Disease (2019-2030)
10.2.3 China Intravitreal Injectable Price by Disease (2019-2030)
11 Asia (Excluding China)
11.1 Asia Intravitreal Injectable Market Size by Drug
11.1.1 Asia Intravitreal Injectable Revenue by Drug (2019-2030)
11.1.2 Asia Intravitreal Injectable Sales by Drug (2019-2030)
11.1.3 Asia Intravitreal Injectable Price by Drug (2019-2030)
11.2 Asia Intravitreal Injectable Market Size by Disease
11.2.1 Asia Intravitreal Injectable Revenue by Disease (2019-2030)
11.2.2 Asia Intravitreal Injectable Sales by Disease (2019-2030)
11.2.3 Asia Intravitreal Injectable Price by Disease (2019-2030)
11.3 Asia Intravitreal Injectable Market Size by Country
11.3.1 Asia Intravitreal Injectable Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Intravitreal Injectable Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Intravitreal Injectable Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Intravitreal Injectable Market Size by Drug
12.1.1 MEALA Intravitreal Injectable Revenue by Drug (2019-2030)
12.1.2 MEALA Intravitreal Injectable Sales by Drug (2019-2030)
12.1.3 MEALA Intravitreal Injectable Price by Drug (2019-2030)
12.2 MEALA Intravitreal Injectable Market Size by Disease
12.2.1 MEALA Intravitreal Injectable Revenue by Disease (2019-2030)
12.2.2 MEALA Intravitreal Injectable Sales by Disease (2019-2030)
12.2.3 MEALA Intravitreal Injectable Price by Disease (2019-2030)
12.3 MEALA Intravitreal Injectable Market Size by Country
12.3.1 MEALA Intravitreal Injectable Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Intravitreal Injectable Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Intravitreal Injectable Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Intravitreal Injectable Value Chain Analysis
13.1.1 Intravitreal Injectable Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Intravitreal Injectable Production Mode & Process
13.2 Intravitreal Injectable Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Intravitreal Injectable Distributors
13.2.3 Intravitreal Injectable Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings